文献速递生殖医学

子宫腺肌症小鼠模型生育力下降与着床期子宫免疫特征改变相关

Reduced fertility in an adenomyosis mouse model is associated with an altered immune profile in the uterus during the implantation period.
PubMed 文献 · Hum Reprod · 2024-01-01

研究在新生CD-1小鼠中用他莫昔芬诱导子宫腺肌症模型,于着床期和妊娠期评估生育力及局部与全身免疫细胞变化。结果TAM组着床点减少、吸收胎增多、每窝胎仔数减少,子宫和脾脏免疫细胞比例与活化状态改变,胎盘血管化与生长相关基因表达降低。

要点

  • 子宫腺肌症小鼠着床点减少、吸收胎增多,平均每窝胎仔数1.00 vs 12.00(P<0.001)。
  • TAM组子宫巨噬细胞、NK细胞和树突状细胞百分比显著下降,但M1巨噬细胞数量增加。
  • TAM组胎盘交界区/迷路区面积比升高,Vegf、Plgf、Pecam和Igf2表达降低。

核心结论

  • 子宫腺肌症小鼠模型生育力下降,与着床期局部和全身免疫改变同时出现。
  • 数据支持先天性和适应性免疫细胞参与该模型中的着床失败和吸收胎增加。

研究设计与样本

  • 随机选择CD-1雌性新生仔鼠,口服他莫昔芬诱导子宫腺肌症(TAM组),对照组仅给予溶剂。
  • 从出生后6周起,两组CD-1小鼠交配,研究着床早期生育力损伤及相关局部和/或全身免疫细胞变化。

主要发现

  • 超声成像显示TAM组着床点数量较少(P<0.005)、吸收胎数量较多(P<0.001),导致窝仔数较少,平均每窝胎仔数TAM组1.00 [0.00; 5.25] vs 对照组12.00 [9.50; 13.75](P<0.001)。
  • E18.5胎盘组织学和形态学分析显示TAM组交界区/迷路区面积比更高(P=0.005)。
  • TAM组血管化和胎盘生长相关基因Vegf(P<0.001)、Plgf(P<0.005)、Pecam(P<0.0001)和Igf2(P=0.002)表达水平降低。
  • TAM组着床期子宫中巨噬细胞、自然杀伤(NK)细胞和树突状细胞(DC)百分比显著下降,但M1巨噬细胞数量增加。
  • TAM组子宫和脾脏中CD4+ T淋巴细胞百分比增加(分别为P=0.0237和P=0.0136),子宫中调节性T细胞数量增加(P=0.036)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 本研究受限于使用动物模型且缺乏干预。
  • 作者指出需要在该领域开展更多研究,以应对受此疾病影响女性的生育挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does a reduction in fertility and/or systemic immune cell change occur during the early implantation period in a mouse model of adenomyosis? SUMMARY ANSWER: A reduction in fertility was observed in mice with adenomyosis, coinciding with local and systemic immune changes observed during the implantation period. WHAT IS KNOWN ALREADY: Adenomyosis is a pathology responsible for impaired fertility in humans, with a still unclear pathophysiology. One hypothesis is that changes in immune cells observed in adenomyosis-affected uteri may alter fertility, notably the physiological immune environment necessary for successful implantation and a healthy pregnancy. STUDY DESIGN, SIZE, DURATION: Randomly selected CD-1 female neonatal pups were orally dosed by administration of tamoxifen to induce adenomyosis (TAM group), while others received solvent only (control group). From 6 weeks of life, CD-1 mice of both groups were mated to study impaired fertility and related local and/or systemic immune cell changes during the early implantation period. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: To evaluate fertility and pregnancy outcomes, ultrasound imaging was performed at E (embryonic day) 7.5 and E11.5 to count the number of gestational sacs and the number of resorptions in eight mice of the TAM group and 16 mice of the control group. The mice were sacrificed at E18.5, and morphometric, functional (quantitative reverse transcription PCR; RT-qPCR), and histological analyses were performed on the placentas. To identify local and/or systemic immune changes during the early implantation period, 8 mice of the TAM group and 12 mice of the control group were sacrificed at E4.5. Uterine horns and spleens were collected for flow cytometry and RT-qPCR analyses to study the immune cell populations. To investigate the profile of the cytokines secreted during the early implantation period at the systemic level, supernatants from stimulated spleen cells were analyzed by multiplex immunoassay analysis. MAIN RESULTS AND THE ROLE OF CHANCE: By ultrasound imaging, we observed a lower number of implantation sites (P < 0.005) and a higher number of resorptions (P < 0.001) in the TAM group, leading to smaller litters (average number of fetuses per litter: 1.00 [0.00; 5.25] in the TAM group versus 12.00 [9.50; 13.75] in the control group (P < 0.001). Histological and morphometric analyses of the placentas at E18.5 showed a higher junctional/labyrinthine area ratio in the TAM group (P = 0.005). The expression levels of genes that play a role in vascularization and placental growth (Vegf (P < 0.001), Plgf (P < 0.005), Pecam (P < 0.0001), and Igf2 (P = 0.002)) were reduced in the TAM group. In the TAM group, the percentages of macrophages, natural killer (NK) cells, and dendritic cells (DC) were significantly decreased in the uterus around the implantation period. However, the number of M1 macrophages was increased. Both macrophages and DC had an increased activation profile (higher expression of MCHII, P = 0.012; CD80, P = 0.015; CCR7, P = 0.043 for macrophages, and higher expression of CD206, P = 0.018; CXCR4, P = 0.010; CCR7, P = 0.006, MCHII, P = 0.010; and CD80, P = 0.012 for DC). In spleen, an increase in the activation of macrophages (CCR7, P = 0.002; MCHII, P = 0.001; and CD80, P = 0.034) and DC was observed in the TAM group (CCR7, P = 0.001; MCHII, P = 0.001; Ly6C, P = 0.015). In the uteri and the spleen, we observed increased percentages of CD4+ T lymphocytes (P = 0.0237 and P = 0.0136, respectively) in the TAM group and, in the uteri, an increased number of regulatory T cells (P = 0.036) compared with the controls. LARGE SCALE DATA: Not applicable. LIMITATIONS, REASONS FOR CAUTION: This study is limited by the use of an animal model and the lack of intervention. WIDER IMPLICATIONS OF THE FINDINGS: These data support involvement of innate and adaptive immune cells in the implantation failure and the increased rate of resorption observed in the mouse model of adenomyosis. This substantiates the need for additional research in this domain, with the goal of addressing fertility challenges in women affected by this condition. STUDY FUNDING/COMPETING INTEREST(S): None.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Bourdon M, Maget AS, Jeljeli M, et al. Reduced fertility in an adenomyosis mouse model is associated with an altered immune profile in the uterus during the implantation period. Hum Reprod. 2024. PMID: 38011900. doi:10.1093/humrep/dead246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。